117516-97-9

Basic information

• Product Name: 2-Thioxo-2,3- dihydrothieno[2,3-d]pyrimidin-4(1H)-one
• Synonyms: 2-Thioxo-2,3- dihydrothieno[2,3-d]pyrimidin-4(1H)-one;2,3-Dihydro-2-thioxothieno[2,3-d]pyrimidin-4(1H)-one;2-Thioxo-2,3-dihydrothieno[2,3-d]pyrimidin-4(1H)-on;2-Thioxo-2,3-dihydro-1H-thieno[2,3-d]pyrimidin-4-one
• CAS NO: 117516-97-9
• Molecular Formula: C6H4N2OS2
• Molecular Weight: 184.243
• Mol File: 117516-97-9.mol
• Article Data: 5

Chemical Properties

• Appearance: /
• Density: 1.65
• Storage Temp.: Sealed in dry,Room Temperature
• CAS DataBase Reference: 2-Thioxo-2,3- dihydrothieno[2,3-d]pyrimidin-4(1H)-one(CAS DataBase Reference)
• NIST Chemistry Reference: 2-Thioxo-2,3- dihydrothieno[2,3-d]pyrimidin-4(1H)-one(117516-97-9)
• EPA Substance Registry System: 2-Thioxo-2,3- dihydrothieno[2,3-d]pyrimidin-4(1H)-one(117516-97-9)

Safety Data

• Hazardous Substances Data: 117516-97-9(Hazardous Substances Data)

Usage

General Description

2-Thioxo-2,3-dihydrothieno[2,3-d]pyrimidin-4(1H)-one is a chemical compound with the molecular formula C7H5N3OS. It is a heterocyclic organic compound containing a thieno[2,3-d]pyrimidine ring system with a thioxo group at the 2-position. 2-Thioxo-2,3- dihydrothieno[2,3-d]pyrimidin-4(1H)-one has potential pharmaceutical applications due to its structural features and biological activities. It is also used as a starting material in the synthesis of various drugs and bioactive compounds. Additionally, it exhibits promising antitumor and antiviral activities, making it an important compound for further research and development in the field of medicinal chemistry.

Upstream product

• 4651-81-4 Methyl 2-aminothiophene-3-carboxylate 
• 31891-06-2 ethyl 2-aminothiophene-3-carboxylate 
• 14080-51-4 2-aminothiophene-3-carboxamide 
• 2720-67-4 potassium propylxanthate 
• 140-89-6 potassium ethyl xanthogenate 

Downstream Products

• 1312701-38-4 (E)-2-(2-benzylidenehydrazinyl)thieno[2,3-d]pyrimidin-4(3H)-one 
• 1312701-39-5 (E)-2-(2-(4-chlorobenzylidene)hydrazinyl)thieno[2,3-d]pyrimidin-4(3H)-one 
• 1312701-40-8 (E)-2-(2-(4-methoxybenzylidene)hydrazinyl)thieno[2,3-d]pyrimidin-4(3H)-one 
• 1312701-41-9 (E)-2-(2-(4-bromobenzylidene)hydrazinyl)thieno[2,3-d]pyrimidin-4(3H)-one 
• 1312701-42-0 (E)-2-(2-(4-methylbenzylidene)hydrazinyl)thieno[2,3-d]pyrimidin-4(3H)-one 
• 1312701-43-1 (E)-2-(2-(3-chlorobenzylidene)hydrazinyl)thieno[2,3-d]pyrimidin-4(3H)-one 
• 1312701-44-2 (E)-2-(2-(3-bromobenzylidene)hydrazinyl)thieno[2,3-d]pyrimidin-4(3H)-one 
• 1312701-45-3 (E)-2-(2-(3-methylbenzylidene)hydrazinyl)thieno[2,3-d]pyrimidin-4(3H)-one 
• 1312701-54-4 1-phenylthieno[3,2-e][1,2,4]triazolo[4,3-a]pyrimidin-5(4H)-one 
• 1312701-55-5 1-(4-chlorophenyl)thieno[3,2-e][1,2,4]triazolo[4,3-a]pyramidin-5(4H)-one 
• 1312701-56-6 1-(4-methoxyphenyl)thieno[3,2-e][1,2,4]triazolo[4,3-a]pyramidin-5(4H)-one 
• 1312701-57-7 1-(4-bromophenyl)thieno[3,2-e][1,2,4]triazolo[4,3-a]pyramidin-5(4H)-one 
• 1312701-58-8 1-p-tolylthieno[3,2-e][1,2,4]triazolo[4,3-a]pyramidin-5(4H)-one 
• 1312701-59-9 1-(3-chlorophenyl)thieno[3,2-e][1,2,4]triazolo[4,3-a]pyramidin-5(4H)-one 

Relevant articles and documents

Development of matrix metalloproteinase-13 inhibitors – A structure-activity/structure-property relationship study

A structure-activity/structure-property relationship study based on the physicochemical as well as in vitro pharmacokinetic properties of a first generation matrix metalloproteinase (MMP)-13 inhibitor (2) was undertaken. After systematic variation of inhi

Synthesis of new 1-phenylthieno[1,2,4]triazolo[4,3-a]pyrimidin-5(4H)-one derivatives

A series of novel 1-phenylthieno[1,2,4]triazolo[4,3-a]pyrimidin-5(4H)-one derivatives 5 and 6 were synthesized by oxidative cyclization of thienopyrimidinonyl hydrazones using iodobenzene diacetate.

Bicyclic pyridine and pyrimidine p38 kinase inhibitors

The present invention discloses compounds corresponding to formula wherein A, R, X, Y, R, R1 and R2 are as defined above, pharmaceutical formulations, methods of making and uses thereof.